Alli Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Orlistat for the Treatment of Type I Hyperlipoproteinemia
Conditions:   Hyperlipoproteinemia Type I;   HypertriglyceridemiaIntervention:   Drug: OrlistatSponsor:   University of Texas Southwestern Medical CenterRecruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2016 Category: Research Source Type: clinical trials